Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

10.25 -0.01 (-0.10%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 Next >
A Look Into Haleon Inc's Price Over Earnings
Via Benzinga
How Is The Market Feeling About Haleon?
Via Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners. 
Via InvestorPlace
GSK: Pharma Giant Prioritizing Shareholder Dividends
A good hunting ground for dividend stocks is often companies from which Wall Street wants to see strong performance in the short-term, while its long-term prospects are actually what are most bright. 
Via Talk Markets
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger 
Via Benzinga
Peering Into Haleon's Recent Short Interest
Via Benzinga
How Is The Market Feeling About Haleon?
Via Benzinga
P/E Ratio Insights for Haleon
Via Benzinga
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
GSK Plc (NYSE: GSK) said it raised £885.6 million ( 
Via Benzinga
How Is The Market Feeling About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)?
Via Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Looking Into Haleon's Recent Short Interest
Via Benzinga
Haleon Lifts Annual Sales Forecasts, Says Pricing & Efficiencies Offset Inflationary Pressures
Haleon PLC (NYSE: HLN) reported  
Via Benzinga
P/E Ratio Insights for Haleon
Via Benzinga
Is GSK Stock Worth Buying Right Now?
GSK stock could be a bargain. 
Via The Motley Fool
A Look Into Haleon Inc's Price Over Earnings
Via Benzinga
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
Reuters 
Via Benzinga
Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products
Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses. 
Via Benzinga
GSK Trims Stake On Consumer Business Spin Off, Raises £804M
GSK Plc (NYSE: GSK) sold 240 mi 
Via Benzinga
Datadog, Compass Diversified, Transocean And This Consumer Health Company: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said "take a small position" in Datadog, Inc. (NASDAQ: DDOG). 
Via Benzinga
GSK: Add This Cheap Chip Play To Your Portfolio
GSK pays a decent quarterly dividend. The latest declared dividend is $0.35 per share, giving GSK a yield of 3.85%. 
Via Talk Markets
KVUE Stock: Should You Buy Into the Kenvue IPO?
KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business. 
Via InvestorPlace
Pharma Giant Pfizer To Start Selling Haleon Stake Within Months, CFO Says
Pfizer Inc (NYSE: PFE) is reportedly looking to start selling its stake in Haleon plc (NYSE: HLN).  
Via Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Via Benzinga
Dow Tumbles 150 Points; Tesla Shares Drop After Q1 Results
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.50% to 33,727.89 while the NASDAQ fell 0.49%... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2023
Via Benzinga
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
Millions of people are scrambling to get their ADHD medication. Here's why. 
Via Investor's Business Daily
Recent Stock Purchase/Sale February 2023
I have been busy buying up some stock this month and was happy to put some fresh and recycled capital to work to try and recoup some of my lost dividend income courtesy of the numerous cuts bestowed... 
Via Talk Markets
Jaguars 27-Point Comeback Costs Sports Bettor $1.4 Million: Here's How And Why No 'Sure Thing' Bet Is Safe
Have you heard the phrase "a sure thing" in sports? The phrase often refers to a sports match that has a winner declared by the public before the game starts, often a matchup between David vs. Goliath... 
Via Benzinga
The Viral “Tripledemic” Opportunity
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu... 
Via Talk Markets
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.